Is IMNM stock safe? | Glauxie AI

Q: Is IMNM stock safe?

Immunome, Inc. (IMNM) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Clay Siegall. Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets... Employees: 200,000.

Q: What are the risks of investing in IMNM?

Identify key risks of investing in IMNM — debt, competition, volatility, and sector headwinds.

Q: Is IMNM a good long-term investment?

Evaluate IMNM as a long-term investment using fundamental scores, growth metrics, and risk assessment.

Q: How much debt does IMNM have?

Review IMNM total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Is IMNM stock safe?

🦉

Immunome, Inc. (IMNM)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOClay Siegall

Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also...

Key Executives

Name	Title
Clay Siegall	Chairman, President & Chief Executive Officer
Jack Higgins	Chief Scientific Officer
Kinney Horn	Chief Business Officer
Max Rosett	Chief Financial Officer
Philip Tsai	Chief Technical Officer
Robert J. Lechleider	Chief Medical Officer

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

IMNM Profile Financials

What are the risks of investing in IMNM? Is IMNM a good long-term investment? How much debt does IMNM have?